The new rapid testing laboratory and jointly developed Thermo Scientific OmnipathTM Combi SARS-CoV-2 IgG ELISA test detects and quantifies antibodies against the coronavirus and increases the University of Oxford’s testing capacity to up to 50,000 tests per day.

Professor Richard Cornall,  Nuffield Professor of Clinical Medicine and Head of the Nuffield Department of Medicine at the University of Oxford said, 'The collaboration is one of a number of projects that we’ve been co-developing with Thermo Fisher and is particularly important because it secures manufacturing and testing capacity that is important for the UK in the next phase of resolving the pandemic.'